Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06061393 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Primary completion date: Sep 20, 2025 to Sep 2027
    • Study sites: 0 to 1
    • Study completion date: Sep 20, 2025 to Dec 2027
    • Start date changed from estimate of Oct 30, 2023 to Nov 2, 2023
    • Eligibility criteria expanded, about 9 words
  2. Start date: Sep 21, 2023 to Oct 30, 2023v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.
Trial Details
NCT Number NCT06061393
Lead Sponsor Western Galilee Hospital-Nahariya
Conditions
(from sponsor)		 Anemia, Iron Deficiency, Pregnancy Anemia
Related terms Anemia, Iron-Deficiency
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov